Embla Medical hf
The answer first
Does Embla Medical beat the market?
No, Embla Medical has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 75% of Nordic stocks
- Quality93
- Value58
- Trend38
No. 29 of 195 in healthcare
Expectations in the price
Low expectations
For the share to return about 9% a year from today's price, the cash Embla Medical keeps must grow about 2% a year for 10 years.
Max for seven days
Follow Embla Medical with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Embla Medical
Your first answer is free, no account needed.
Do you own Embla Medical, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Embla Medical and a few more. Free, no card.
Super Stock+44.6%In short
- Embla Medical has fallen 16.6% over the past year, including dividends.
- Overall, Embla Medical ranks better than 75% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 47.2%. The price is 51.3% below its peak now.
What do analysts think of Embla Medical?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 75% of Nordic stocks.
No. 29 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 22 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.55
- Asset turnoverSales divided by everything the company owns0.60
- Return on equityProfit divided by equity+10.1%
- Cash conversionOperating cash flow divided by profit1.47
The ranking is built on equity ratio, ROA and how steadily profit grows.
Medium Fair price: about the same as a typical Nordic stock.
No. 32 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity1.8
- P/SPrice divided by sales1.7
- P/EPrice divided by earnings18.2
- P/CFPrice divided by operating cash flow12.3
The ranking is built on P/E, P/B and P/S.
Medium The share price has moved about like most stocks over the last year.
No. 88 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−8.8%
- 6 months+1.5%
- 9 months−8.8%
- 12 months−16.6%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Embla Medical
12 funds we follow own Embla Medical. The share is how much of the fund the stock makes up.
- Norway2
- Sweden6
- Denmark4
- Handelsbanken Norden Selektiv (A1 NOK)Sweden · Handelsbanken1.5%
- Protean Aktiesparfond Norden ASweden · Protean1.3%
- ODIN Norden CNorway · ODIN1.0%
- Handelsbanken Europa Småbolag (A1 NOK)Sweden · Handelsbanken0.9%
- Handelsbanken Europa Småbolag A10 NOKSweden · Handelsbanken0.9%
- Handelsbanken Nordiska Småbol (A1 NOK)Sweden · Handelsbanken0.3%
- BIX Danske Aktier Indeks ADenmark · BIX0.2%
- BIX Danske Aktier Indeks Akk ADenmark · BIX0.2%
From the funds' latest known holdings.
About Embla Medical
Embla Medical hf is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 4,500 employees.
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints.


See the full analysis of Embla Medical.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card